Hemp extracts have been used for medicinal purposes for millennia – but various laws have prevented research and development. Our research aims to better understand the plant, its compounds and its potential health benefits.
Currently, our research is interested in the cannabinoids present in the cannabis plant and looks at methods for effective extraction. Our research also looks at the plant and how it might be used in commercial therapeutics.
Given the history of cannabis and recent legislative changes, the context in Australia is ripe for medicinal cannabis research.
In mid-2014, NSW Premier Mike Baird initiated a working group to establish a medicinal cannabis trial in NSW. He then established the $12 million NSW Centre for Medicinal Cannabis Research and Innovation and funded clinical trials to commence in 2016.
The Lambert Initiative was established in 2015 by the Lambert family and in 2016 they founded The Lambert Center for the Study of Medicinal Cannabis and Hemp at Thomas Jefferson University in Philadelphia. Both centres are collaborating closely to further education and research.
Since the Australian Government legalised medicinal cannabis in 2016, our scientists and researchers can now undertake vital research to change the lives of millions of people living with incurable conditions, addictions and mental illness.
We partner with a number of commercial organisations, including Australia’s leading industrial hemp producer Ecofibre Industries Operations and Canada’s leading medical cannabis supplier Tilray.
Through our trusted partners we acquire THC tablets, cannabis flowers, cannabinoid compounds for our pre-clinical research, medical cannabis to standards required for human therapeutic use, and matching placebos for clinical research purposes.
Hemp extracts and health